IBRX

ImmunityBio, Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$6.07

Price (1 Year)

$10.51 $2.02

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %31.3 / %30
Non-compliant assets / Total market cap %7.2 / %30
Non-compliant revenue / Total income %6 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system and deliver durable protection against cancer and infectious diseases. Its platforms for the development of biologic products and product candidates that include cytokine fusion proteins, DNA and vaccine vectors, and cell therapies.

Website

Analysis (Turkish): IBRX Hissesi Caiz mi, Helal mi? ImmunityBio, Inc. Katılım Analizi